Jing, C., Mao, X., Wang, Z., Sun, K., Ma, R., Wu, J., & Cao, H. (2018). Next-generation sequencing-based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her-2 and TP53 mutations in patients with non-small cell lung cancer. Mol Med Rep.
Styl cytowania ChicagoJing, Changwen, Xuhua Mao, Zhuo Wang, Kejing Sun, Rong Ma, Jianzhong Wu, i Haixia Cao. "Next-generation Sequencing-based Detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her-2 and TP53 Mutations in Patients With Non-small Cell Lung Cancer." Mol Med Rep 2018.
Styl cytowania MLAJing, Changwen, et al. "Next-generation Sequencing-based Detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her-2 and TP53 Mutations in Patients With Non-small Cell Lung Cancer." Mol Med Rep 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..